Biolight treats decubitus ulcers
This article was originally published in Clinica
Two phase III studies carried out in Sweden and Denmark of a new handheld device for treating decubitus ulcers have shown that it can significantly reduce the time the ulcers take to heal. The device, the Biolight Care Device, is manufactured by the Swedish company, Biolight International.
You may also be interested in...
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.
Months of pandemic-induced disruption to health care systems and freedom of movement undoubtedly carries a cost. For the biopharmaceutical industry, this can be mitigated by its essential role in providing therapeutic interventions and leading the fightback via prophylactic vaccines. This softens the blow somewhat, certainly compared to other industries that are fully exposed to COVID-19 headwinds.